The National Screening Committee (NSC) has published its first annual reportl. The Committee identified almost three hundred screening programmes in the UK, many of them at the research stage but nearly a hundred currently in practice. Only four programmes (breast and cervical screening, and neonatal bloodspot screening for phenylketonuria and hypothyroidism) met the Committee's stringent criteria for both quality and evidence of effectiveness. Furthermore the quality of the breast and cervical screening undertaken in some areas of the UK screening framework with agreed definitions and classifications of population screening programmes; a National Screening Handbook which specifies the most important issues for managing screening programmes; setting up of an antenatal subgroup to look specifically at screening around pregnancy; and guidance notes for those undertaking research. The future work of the NSC will be in two main areas development of policy and improvement of the quality of screening programmes. It is in these two areas that the NSC will be judged. On the policy front the early signs are encouraging. Ministers have accepted the Committee's recommendation that prostate cancer screening should not be introduced until there is clear evidence of a beneficial effect of screening, and research has been commissioned into this area under the Health Technology Assessment programme. Ministers have also accepted the NSC's recommendation to introduce universal screening for hepatitis B in pregnancy. Health authorities and boards will be asked to implement this programme, with a proposed start date of April 2000. Responding to the doubts about the quality of the breast screening in Exeter and the cervical screening in Kent the Committee reviewed the quality assurance mechanisms of these programmes. The arrangements for quality assurance in both programmes in England have been revised, and we shall see whether real quality improvements are achieved. Screening programmes affect the whole population and involve all sectors of the National Health Service. The arrival of the National Screening Committee should be widely welcomed.
